Back to
Capital World Investors
REGN29 quarters
Position history for
Capital World Investors's holdings in REGENERON PHARMACEUTICALS
Yes. Capital World Investors holds 814,925 shares of REGN (Regeneron Pharmaceuticals), worth $508.1M, as of its Q2 2026 13F filing. It reduced the position by 604,075 shares (-42.6%) from Q1 2026. Capital World Investors has held REGN in every 13F on record since Q2 2019, 29 quarterly filings. REGN is 0.1% of Capital World Investors' reported 13F portfolio.
Current Value
$508.1M
Current Shares
814,925
Total Value Change
-$2B
Total Shares Change
-7.3M
Quarter-by-Quarter History
Other major holders of REGN: FMR LLC, VANGUARD GROUP INC